Molecular Biomarkers of Anaplastic Thyroid Carcinoma

Author(s): F. Bozorg-Ghalati*, M. Hedayati

Journal Name: Current Molecular Medicine

Volume 17 , Issue 3 , 2017

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor


Anaplastic thyroid carcinoma is the rarest but extremely aggressive thyroid cancer subtype. This neoplasia is composed of undifferentiated tumor cells with poor prognosis and resistant to common thyroid cancer therapy. Early stage identification of this cancer for prompt treatment is very vital. Presently, cytological evaluation of fine needle aspiration biopsy (FNAB) which is known as invasive recognition assay, is the standard diagnostic method for the diagnosis of malignant thyroid tumors. Frequent studies have suggested that using the molecular biomarkers of thyroid cancer tissue alongside cytological examination, increase the accuracy of diagnostic tests. Also, these agents could be beneficial for effective target therapy and personalize medicine. In this review, the molecular biomarkers that are involved in anaplastic thyroid carcinoma in four category (gene mutation profile, epigenetic profile, microRNA profile and cancer stem cell markers) were summarized.

Keywords: Anaplastic thyroid carcinoma, molecular biomarkers, gene mutation profile, epigenetic profile, microRNA profile, cancer stem cell markers.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2017
Page: [181 - 188]
Pages: 8
DOI: 10.2174/1566524017666170822102417
Price: $65

Article Metrics

PDF: 53
HTML: 15